Concerns raised over integrity of mRNA molecules in some COVID-19 vaccines
Findings highlight the fragilities of the manufacturing process, but companies aren't willing to release information, BMJ report suggests.
Published
Join OnMedica and benefit from:
- Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
- High-quality, evidence-based content developed by expert editors and clinicians
- Articles, quizzes, videos, visual summaries and more
- Regulatory alerts and round-up of medical journals
- New content added daily, so you know you’re always up to date
